Navigation Links
Vitamin C lowers levels of inflammation biomarker considered predictor of heart disease
Date:11/13/2008

percent lower levels of CRP with vitamin C compared with a placebo.

The UC Berkeley study also found a strong link between obesity and elevated levels of CRP. The researchers found that while 25 percent of normal-weight people had elevated levels of CRP, those levels were found in 50 percent of overweight and 75 percent of obese participants.

"The low-grade inflammation that characterizes obesity is believed to contribute to a number of disorders, including atherosclerosis and insulin resistance," said Nina Holland, adjunct professor at UC Berkeley's Division of Environmental Health Sciences and co-investigator on the study. Holland's biorepository at UC Berkeley processed and stored the thousands of blood samples involved in this study.

Notably, the American Heart Association and the U.S. Centers for Disease Control and Prevention recommends that clinicians measure CRP levels in patients who have a moderately elevated risk of cardiovascular problems, as determined by other established risk factors such as high cholesterol levels and smoking.

"Major studies have found that the level of CRP in the body predicts future risk of cardiovascular disease, including myocardial infarction, stroke and peripheral artery disease, as well as diabetes," said Block. "Some believe CRP to be as important a predictor of future heart problems as high levels of LDL and low levels of HDL cholesterol."

The UC Berkeley-led study looked at the separate effects of two antioxidants: vitamin C and vitamin E. The researchers randomly divided 396 healthy, non-smoking adults from the San Francisco Bay Area into groups taking daily doses of either 1,000 milligrams of vitamin C, 800 international units of vitamin E or a placebo. The recommended dietary allowance (RDA) for vitamin C is 90 milligrams per day for men and 75 milligrams per day for women. The researchers noted that the suggested upper limit for vitamin C is 2,000 milligrams per day, or twice
'/>"/>

Contact: Sarah Yang
scyang@berkeley.edu
510-643-7741
University of California - Berkeley
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Could vitamin D save us from radiation?
2. Lung airway cells activate vitamin D and increase immune response
3. Optimal dose of vitamin E maximizes benefits, minimizes risk
4. Vitamin K does not stem BMD decline in postmenopausal women with osteopenia
5. Lack of vitamin D linked to Parkinsons disease
6. Vitamin D a key player in overall health of several body organs, says UC Riverside biochemist
7. Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
8. Dont forget the vitamin A when working with its carrier protein
9. Variant of vitamin D receptor gene linked to melanoma risk
10. Majority of osteoporosis patients not receiving calcium and vitamin D with treatment
11. Vitamin A pushes breast cancer to form blood vessel cells

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)...ch Centre, a partnership of the University of Brit...stal Health Research Institute, have uncovered new...lls die following a stroke, as well as a possible ...udy were recently published online in Nature Medi...ntinue to die even after blood flow has been resto...
(Date:11/20/2009)...ead studies about the health benefits of having a ...lar level, where amino acids known as cysteines ar...when paired up with other cysteines. , Now, rese...colleagues in Belgium, have discovered a new antio...research appears in the Nov. 20 issue of the journ...
(Date:11/20/2009)...09) Scientists from the Marine Biogeochemistry an...earch Laboratory (NRL) organized and led a team of... expedition to initiate methane hydrate exploratio...riation of sediment contribution to Arctic climate... Polar Sea as a research platform, three cross-she...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2Saving the single cysteine: New antioxidant system found 2International expedition investigates climate change, alternative fuels in Arctic 2Echo Therapeutics Initiates Clinical Study of its New One Piece Symphony 28TM 29 tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 5982 1Echo Therapeutics Initiates Clinical Study of its New One Piece Symphony 28TM 29 tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 5982 2Echo Therapeutics Initiates Clinical Study of its New One Piece Symphony 28TM 29 tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 5982 3Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products 5980 1Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products 5980 2Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products 5980 3Codexis Names Fernando Valle Research Fellow 5978 1Codexis Names Fernando Valle Research Fellow 5978 2
...f problems is among the greatest challenges to the...ion alone is becoming more problematic in the worl... sources, such as polluted rivers, lakes and groun...lated," says Bruce Rittmann, director of the Cente... Institute at ASU. "For example, most of the pollu...
...,s role in controlling appetite and weight, resear...ave shown that reducing levels of fatty acids in t...obese. Their results suggest that restoring fatty-... treat obesity. The study, published in the Januar... led by Dr. Luciano Rossetti, director of the Diab...
...ood pollinators, especially in species-rich biodiv...roceedings of the National Academy of Science (PNA... the University of Calgary and Tiffany Knight, Ph....ciences at Washington University in St. Louis, and...global analysis of more than 1,000 pollination stu...
Other Biology News:Earth Rx: A microbial biotechnology prescription for global environmental health 2Earth Rx: A microbial biotechnology prescription for global environmental health 3Study by Einstein researchers could lead to a novel strategy for treating obesity 2Study: Competition for sex is a 'jungle out there' 2
(Date:11/19/2009)...RNewswire-FirstCall/ -- Omeros Corporation (Nasdaq...lts for the third quarter ended September 30, 2009...meros reported a net loss of $3.9 million, or $1.3...lion, or $2.54 per share, for the same period in 2... the Company reported a net loss of $15.5 million,...
(Date:11/19/2009)... 19 Spherix Incorporated...or diabetes therapy, and a provider of technical a...ent, biotechnology and pharmaceutical companies, t...ting of Shareholders. ,, At the meeting, shareh...ected the following members to the Board of Direct...
(Date:11/19/2009)...LASIK surgeons and recognized refractive and catar...ns made brought their fellow surgeons up-to-date o...gery, cataract surgery, and ophthalmology in gener...phthalmology (AAO) annual meeting in San Francisco...auber, Dr. David Huang, MD, Dr. Randy Epstein, Dr....
(Date:11/18/2009)...18 Marrone Bio Innovations (MBI), ...ialization of effective and environmentally respon...has been named an IC20 company by the Investors, C...nal angel investing group. ,, Companies named t...ng results for all stakeholders, including investo...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9Marrone Bio Innovations Named an IC20 Company 2
...tar,Therapeutics (Nasdaq: NKTR ) will announce it...rch 31, 2008 on Wednesday, May 7, 2008, after the,...n, president and chief,executive officer, will hos... Time (ET)., Investors can access the press relea... call through a link that is posted on the Investo...
... BTV8 vaccine released to supply Northern ...therlands, April 30 ,Intervet/Schering-Plough Anim...f Bovilis BTV8 vaccine against bluetongue to suppl...ombining after the acquisition in 2007 the,strengt...s not only the,world market leader in the producti...
... Squibb,Company (NYSE: BMY ) invites investors an... annual meeting with stockholders at 10 a.m. ET on...er and board items to be,transacted, senior execut...ess., For information on how to listen to the web...the Bristol-Myers Squibb website at, http://www.bm...
Other Biology Technology:Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets 2Intervet/Schering-Plough Animal Health Outlines Strength of the Combination 2Intervet/Schering-Plough Animal Health Outlines Strength of the Combination 3
HeLa Cell Slide from ProSci, Inc
Anti-YAP, phospho (Ser127) Antibody, Unconjugated from Cell Signaling Technology
EL4 Cell Slide from ProSci, Inc
BALB/3T3 Cell Slide from ProSci, Inc
Biology Products: